Skip to main page content

Dr. Ryan Eidsness, MD, FRCSC

Participates in 12 items

Sessions in which Dr. Ryan Eidsness, MD, FRCSC participates

sexta-feira 14 junho, 2019

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

domingo 16 junho, 2019

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
10:45
10:45 - 12:15 | 1 hour 30 minutes
OculoplasticsSkills Transfer Course (STC)

sexta-feira 10 junho, 2022

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
13:00
13:02 - 13:09 | 7 minutes
Oculoplastics

Authors: Ryan Eidsness, Malshi Kurunatilake, Mussawar Iqbal. University of Saskatchewan.Author Disclosure Block: R. Eidsness: None. M. Kurunatilake: None. M. Iqbal: NoneAbstract Body:Purpose: Discuss a case of advanced Squamous cell carcinoma (SCC) involving the eyelid, conjunctiva, and orbit that responded to Cemiplimab (Libtayo)Study Design: Study design: Case Study...

sexta-feira 20 junho, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
11:20
11:35
11:50
12:05
12:20
12:35
14:05
14:07 - 14:14 | 7 minutes

Author’s Name(s): Ryan Eidsness, Seyedeh Zahra (Mona) Moossavi, Alexa MateriAuthor’s Disclosure Block: Ryan Eidsness, none; Seyedeh Zahra (Mona) Moossavi, none; Alexa Materi, noneAbstract BodyPurpose: The Purpose: of this study is to present my experience with the use of topical Imiquimod 5% for periocular BCC. BCC makes up >90% of all periocular malignancies. Non-surgical management of tumors are becoming increasingly im...

14:20

Sessions in which Dr. Ryan Eidsness, MD, FRCSC attends

sexta-feira 16 junho, 2023

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
8:00
8:00 - 10:00 | 2 hours
Current Concepts

 Learning Objectives:At the end of this session, participants will be able to:Review how to apply Quality Improvement strategies to improve patient safetyBe familiar with the presentation and histology of hereditary benign intraepithelial dyskeratosis, and be able to distinguish it from other conjunctival lesions including conjunctival intraepithelial neoplasia.Des...

10:45
10:45 - 12:15 | 1 hour 30 minutes
Oculoplastics

 Learning Objectives: At the end of this session, participants will be able to: Recognize orbital imaging findings of ocular conditions and surgeriesDescribe the various medical management options for Thyroid Eye DiseaseManage infections of...

11:55
13:30
13:30 - 15:00 | 1 hour 30 minutes
Oculoplastics

 Learning Objectives: At the end of this session, participants will be able to: Integrate novel research ideas into clinical practice  Describe key research outcomes in oculoplastics CanMEDS Roles: Scholar, Medical ExpertX

15:45
15:45 - 17:15 | 1 hour 30 minutes
Oculoplastics

 Learning Objectives: At the end of this session, participants will be able to: Integrate oncological principles in the management of oculoplastics disordersCanMEDS Roles: Medical Expert, Professional

17:15
17:15 - 18:30 | 1 hour 15 minutes
Oculoplastics